National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant fowlpox-tyrosinase vaccine
A recombinant fowlpox virus vaccine with potential antineoplastic activity. Binding to the melanoma antigen tyrosinase, recombinant fowlpox-tyrosinase vaccine generates cellular immune responses against melanoma cells expressing the tyrosinase antigen; this effect is enhanced by the co-administration of interleukin 2 (IL-2). Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:rF-TYR vaccine (Tyrosinase-Fowl Pox)
Abbreviation:rF-TYR Vaccine



Previous:recombinant fowlpox GM-CSF vaccine adjuvant, recombinant fowlpox-B7.1 vaccine, recombinant fowlpox-CEA(6D)/TRICOM vaccine, recombinant fowlpox-prostate apecific antigen vaccine, recombinant fowlpox-TRICOM vaccine
Next:recombinant human 6Ckine, recombinant human chorionic gonadotropin, recombinant human EGF-rP64K/Montanide ISA 51 vaccine, recombinant human endostatin, recombinant human growth hormone

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov